Senti Biosciences, Inc.SNTINASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.31
↑ 95% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-6.32
Historical baseline
PeriodValueYoY Change
2024-0.31+25.9%
2023-0.41+61.3%
2022-1.06+86.3%
2021-7.78+64.5%
2020-21.94-242.3%
2019-6.41-